• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    CLS Holdings USA Buys Entry to Adult Market in Massachusetts

    Bryan Mc Govern
    Sep. 23, 2019 04:20PM PST
    Cannabis Investing News
    CSE:CLSH

    CLS Holdings USA earned a positive review after securing entry to the recreational cannabis market in Massachusetts, which legalized adult-use sales last year.

    CLS Holdings USA (CSE:CLSH,OTCQB:CLSH) has completed a “major milestone,” in the eyes of one analyst, by securing a recreational marijuana state license holder in Massachusetts.

    CLS has an option to acquire the license holder, In Good Health, a local medical dispensary based in Brockton. It received its recreational license for the state last Tuesday (September 17).

    According to CLS, In Good Health currently serves over 25,000 enrolled patients and its entire operation could generate US$60 million in revenue a year, with gross profits of US$35 million.

    In a statement, Jeff Binder, chairman and CEO of the public firm, said the license was one of the first to be handed out in the state. The executive added that he expects only 27 recreational licenses for retailers in Massachusetts, including the one for In Good Health.

    The New England state launched sales of adult-use marijuana in November 2018.

    CLS plans to roll out the sale of recreational cannabis products “in the coming weeks.” 

    “…We expect that In Good Health will quickly build a large and loyal customer base in the recreational cannabis market and become one of the larger recreational use dispensaries in the state,” Andrew Glashow, president and COO of CLS, said in a statement.

    In a research note to investors, Canaccord Genuity praised the deal for CLS. However, the note indicates that the firm will most likely still need financial support to complete the acquisition of In Good Health.

    Canaccord Genuity has a one year price target of C$1.50 for CLS. Shares of the US company opened on Monday (September 23) at a price of C$0.32.

    The public firm expects to complete its acquisition of the cannabis company in January 2020.

    According to data from Marijuana Business Daily, as of May, sales of recreational marijuana in the state had reached just under US$140 million in the aggregate since legalization.

    Don’t forget to follow us @INN_Cannabis for real-time news updates!

    Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

    cls holdings usacse:clshjeff bindercannabis investingin good healthotc:clsh
    The Conversation (0)

    Go Deeper

    AI Powered
    Cannabis business with marijuana leaves and stock

    Cannabis Market 2024 Year-End Review

    CSE:CL

    Cannabis Weekly Round-Up: CannTrust Faces Possible Delisting

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×